A chemical to make brain cells grow: Mental decline thwarted in aging rats

July 8, 2010
The neuroprotective compound P7C3 was discovered by testing more than 1000 small molecules in living mice. Credit: Andrew Pieper, M.D., Ph.D., UT Southwestern Medical Center

Scientists have discovered a compound that restores the capacity to form new memories in aging rats, likely by improving the survival of newborn neurons in the brain's memory hub. The research, funded in part by the National Institutes of Health, has turned up clues to a neuroprotective mechanism that could lead to a treatment for Alzheimer's disease.

"This neuroprotective compound, called P7C3, holds special promise because of its medication-friendly properties," explained Steven McKnight, Ph.D., who co-led the research with Andrew Pieper, M.D., Ph.D., both of University of Texas Southwestern Medical Center, Dallas. "It can be taken orally, crosses the blood-brain barrier with long-lasting effects, and is safely tolerated by mice during many stages of development."

The researchers report on their findings July 9, 2010 in the journal Cell. Their work was funded, in part, by the NIH's National Institute of Mental Health (NIMH), a NIH Director's Pioneer Award funded through the Common Fund and managed by the National Institute of General Medical Sciences, and National Cancer Institute.

"This striking demonstration of a treatment that stems age-related cognitive decline in living animals points the way to potential development of the first cures that will address the core illness process in ," said NIMH Director Thomas Insel, M.D.

Physical activity, social, or other enriching experiences promote neurogenesis - the birth and maturation of new . This growth takes place in the dentate gyrus, a key area of the brain's memory hub, the hippocampus. But even in the normal adult brain, most of these newborn neurons die during the month it takes to develop and get wired into . To survive, the cells must run a gauntlet of challenges. Newborn hippocampus neurons fare much worse in aging-related disorders like Alzheimer's, marked by runaway cell death.

In hopes of finding compounds that might protect such vulnerable neurons during this process, Pieper, McKnight and colleagues tested more than 1000 small molecules in living mice. One of the compounds, designated P7C3, corrected deficits in the brains of adult mice engineered to lack a gene required for the survival of newborn neurons in the hippocampus. Giving P7C3 to the mice reduced programmed death of newborn cells - normalizing stunted growth of branch-like neuronal extensions and thickening an abnormally thin layer of cells by 40 percent. Among clues to the mechanism by which P7C3 works, the researchers discovered that it protects the integrity of machinery for maintaining a cell's energy level.

Aged rats treated with P7C3 performed significantly better on a memory test than control rats treated with an inactive substance (veh). This was traced to a three-fold higher number of newborn neurons in the dentate gyrus area of the hippocampus. Credit: Andrew Pieper, M.D., Ph.D., UT Southwestern Medical Center

To find out if P7C3 could similarly stem aging-associated neuronal death and , the researchers gave the compound to aged rats. Rodents treated with P7C3 for two months significantly outperformed their placebo-treated peers on a water maze task, a standard assay of hippocampus-dependent learning. This was traced to a threefold higher-than-normal level of newborn neurons in the dentate gyrus of the treated animals. Rats were used instead of mice for this phase of the study because the genetically engineered mice could not swim.

The researchers pinpointed a derivative of P7C3, called A20, which is even more protective than the parent compound. They also produced evidence suggesting that two other neuroprotective compounds eyed as possible Alzheimer's cures may work through the same mechanism as P7C3. The A20 derivative proved 300 times more potent than one of these compounds currently in clinical trials for Alzheimer's disease. This suggested that even more potent neuroprotective agents could potentially be discovered using the same methods. Following up on these leads, the researchers are now searching for the molecular target of P7C3 - key to discovering the underlying neuroprotective mechanism.

More information: References:

-- Discovery of a Pro-neurogenic, Neuroprotective Chemical. Pieper AA, Xie S, Capota E, Estill SJ, Zhong J, Long JM, Becker GL, Huntington P, Goldman SE, Shen CH, Capota M, Britt JK, Kotti T, Ure K, Brat DJ, Williams NS, MacMillan KS, Naidoo J, Melito L, Hsieh J, Brabander JD, Ready JM, McKnight SL. 2010, Jul 8. Cell, DOI:10.1016/j.cell.2010.06.018

-- A selective allosteric potentiator of the M1 muscarinic acetylcholine receptor increases activity of medial prefrontal cortical neurons and restores impairments in reversal learning. Shirey JK, Brady AE, Jones PJ, Davis AA, Bridges TM, Kennedy JP, Jadhav SB, Menon UN, Xiang Z, Watson ML, Christian EP, Doherty JJ, Quirk MC, Snyder DH, Lah JJ, Levey AI, Nicolle MM, Lindsley CW, Conn PJ. J Neurosci. 2009 Nov 11;29(45):14271-86.PMID: 19906975

-- Discovery and Characterization of Novel Subtype-Selective Allosteric Agonists for the Investigation of M1 Receptor Function in the Central Nervous System. Lebois EB, Bridges TM, Lewis LM, Dawson ES, Kane AS, Xiang S, Jadhav SB, Yin H, Kennedy JP, Meiler J, Niswender CM, Jones CK, Conn PJ, Weaver DC and Lindsley CW. ACS Chem. Neurosci., 2010, 1 (2), pp 104-121, September 25, 2009. DOI: 10.1021/cn900003h

Related Stories

Recommended for you

Nature or nurture? Innate social behaviors in the mouse brain

October 18, 2017
Adult male mice have a simple repertoire of innate, or instinctive, social behaviors: When encountering a female, a male mouse will try to mate with it, and when encountering another male, the mouse will attack. The animals ...

Brain activity predicts crowdfunding outcomes better than self-reports

October 18, 2017
Surveys and self-reports are a time-honored way of trying to predict consumer behavior, but they have limitations. People often give socially desirable answers or they simply don't know or remember things clearly.

Brain-machine interfaces to treat neurological disease

October 18, 2017
Since the 19th century at least, humans have wondered what could be accomplished by linking our brains – smart and flexible but prone to disease and disarray – directly to technology in all its cold, hard precision. Writers ...

Changing stroke definitions is causing chaos, warns professor

October 18, 2017
Proposals to change the definitions of stroke and related conditions are causing confusion and chaos in clinical practice and research, a Monash University associate professor has warned.

Scientists may have found a cause of dyslexia

October 18, 2017
A duo of French scientists said Wednesday they may have found a physiological, and seemingly treatable, cause for dyslexia hidden in tiny light-receptor cells in the human eye.

Navigational view of the brain thanks to powerful X-rays

October 18, 2017
If brain imaging could be compared to Google Earth, neuroscientists would already have a pretty good "satellite view" of the brain, and a great "street view" of neuron details. But navigating how the brain computes is arguably ...


Adjust slider to filter visible comments by rank

Display comments: newest first

3 / 5 (1) Jul 08, 2010
When you compare the effects of this chemical with that of cannabanoids such as THC (more new neurons!), and see the similar structures of the molecules, you start to wonder what the real effects of marijuana on memory are. Maybe pot decreases memory in some ways because producing so many new neurons disrupts memories, but it maintains creativity by allowing formation of new circuits with those new neurons. Whatever the case, we should definitely be doing 10-100 times more research on the effects of THC since a huge fraction of the population regularly uses this substance.
not rated yet Jul 08, 2010
Can't wait to get some some!
H+ rules...
not rated yet Jul 09, 2010
Gacyclidine also looks promising in this area.
not rated yet Jul 09, 2010
paul - I understand what you're getting at, but I think you are misunderstanding the current research on the effect of cannabinoids on receptors in the human brain. There are alot of unanswered questions on the use of marijuana that have yet to be answered in a sufficiently controlled manner like this study in the article.

I like what they're reporting about this, especially given the safe large doses it suggests the mice are taking to achieve this. Question posed is what a problem it will be to get passed through FDA and how much it will be charged for...
not rated yet Jul 09, 2010
The flip side of enhancing cell srvival is the promotion of tumors - I wonder if the samples was large enough to detect any such effect?
not rated yet Jul 11, 2010
I think this particular method is safe against tumors because it doesn't prolong cell survival, it simply shields the younger cells from the harsh environment they are born into. Once the cells mature, they become regular neurons that will still experience programmed cell death at the correct time. Though the article doesn't specify whether the compound also protects already mature neurons, but from what I can see it doesn't affect PCD mechanisms, so it shouldn't cause cells to go cancerous.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.